Cytokine release syndrome prophylaxis strategy with dipyrone in patients receiving bispecific Antibodies—Elranatamab, teclistamab, talquetamab and Epcoritamab—at a private hospital in southern Brazil: Preliminary Results
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Erica Ottoni, Emanuelle Ortiz, Julia Portich, Rafaela Dal Molin, Dani Laks, Flavo Fernandes
Institution: Hospital Moinhos de Vento
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417018144
Cites:
Cited by:
Related to: